1. Home
  2. GL vs MDGL Comparison

GL vs MDGL Comparison

Compare GL & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globe Life Inc.

GL

Globe Life Inc.

HOLD

Current Price

$140.09

Market Cap

11.3B

Sector

Finance

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$582.02

Market Cap

12.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GL
MDGL
Founded
1900
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3B
12.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GL
MDGL
Price
$140.09
$582.02
Analyst Decision
Buy
Strong Buy
Analyst Count
10
14
Target Price
$160.00
$580.77
AVG Volume (30 Days)
489.6K
268.0K
Earning Date
02-04-2026
11-04-2025
Dividend Yield
0.77%
N/A
EPS Growth
16.72
N/A
EPS
13.77
N/A
Revenue
$5,940,974,000.00
$740,640,000.00
Revenue This Year
$7.48
$435.63
Revenue Next Year
$5.31
$52.56
P/E Ratio
$10.15
N/A
Revenue Growth
3.73
864.21
52 Week Low
$109.38
$265.00
52 Week High
$147.83
$615.00

Technical Indicators

Market Signals
Indicator
GL
MDGL
Relative Strength Index (RSI) 52.37 56.02
Support Level $140.58 $578.00
Resistance Level $144.44 $592.72
Average True Range (ATR) 2.32 17.07
MACD -0.12 -2.38
Stochastic Oscillator 22.15 57.96

Price Performance

Historical Comparison
GL
MDGL

About GL Globe Life Inc.

Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: